98 related articles for article (PubMed ID: 9167006)
1. Japanese encephalitis and dengue vaccines.
Barrett AD
Biologicals; 1997 Mar; 25(1):27-34. PubMed ID: 9167006
[No Abstract] [Full Text] [Related]
2. Japanese encephalitis vaccine including a preliminary report on dengue fever and Chikungunya vaccines.
Kitaoka M
Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():41-56. PubMed ID: 4297905
[No Abstract] [Full Text] [Related]
3. From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.
Brandt WE
J Infect Dis; 1990 Sep; 162(3):577-83. PubMed ID: 1696952
[No Abstract] [Full Text] [Related]
4. Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.
Saluzzo JF
Adv Virus Res; 2003; 61():419-43. PubMed ID: 14714439
[No Abstract] [Full Text] [Related]
5. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
Joshi AM; Walimbe AM; Banerjee K
Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
[TBL] [Abstract][Full Text] [Related]
6. Vaccines aplenty.
Halstead SB
Curr Opin Infect Dis; 2002 Oct; 15(5):461-3. PubMed ID: 12686876
[No Abstract] [Full Text] [Related]
7. [Increase attention to vaccination against Japanese encephalitis].
Friman G; Proos L; Trolin I; Böttiger M; Lundbergh P
Lakartidningen; 1992 Nov; 89(46):3918, 3921. PubMed ID: 1334183
[No Abstract] [Full Text] [Related]
8. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
9. Concepts of control of Japanese encephalitis and dengue.
Shope RE
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 2():131-4. PubMed ID: 9561649
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
Guo W; Li L; Wu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
[TBL] [Abstract][Full Text] [Related]
11. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.
Chambers TJ; Tsai TF; Pervikov Y; Monath TP
Vaccine; 1997 Oct; 15(14):1494-502. PubMed ID: 9330458
[No Abstract] [Full Text] [Related]
12. Evidence of the partial effects of inactivated Japanese encephalitis vaccination: analysis of previous outbreaks in Japan from 1953 to 1960.
Satou K; Nishiura H
Ann Epidemiol; 2007 Apr; 17(4):271-7. PubMed ID: 17300956
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis: development of new candidate vaccines.
Bharati K; Vrati S
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis vaccines: moving away from the mouse brain.
Zanin MP; Webster DE; Martin JL; Wesselingh SL
Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
[TBL] [Abstract][Full Text] [Related]
15. Long persistence of anti-dengue antibodies in the serum of native residents of some Japanese main islands.
Hotta S; Yamamoto M; Tokuchi M; Sakakibara S
Kobe J Med Sci; 1968 Jun; 14(2):149-53. PubMed ID: 4303075
[No Abstract] [Full Text] [Related]
16. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells.
Appaiahgari MB; Vrati S
Vaccine; 2004 Sep; 22(27-28):3669-75. PubMed ID: 15315846
[TBL] [Abstract][Full Text] [Related]
17. Acute undifferentiated fever caused by infection with Japanese encephalitis virus.
Watt G; Jongsakul K
Am J Trop Med Hyg; 2003 Jun; 68(6):704-6. PubMed ID: 12887030
[TBL] [Abstract][Full Text] [Related]
18. [Future prospects in developing of dengue vaccines].
Valero N; Levy A
Invest Clin; 2008 Jun; 49(2):135-8. PubMed ID: 18717261
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
20. Recent advancement in flavivirus vaccine development.
Chang GJ; Kuno G; Purdy DE; Davis BS
Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
